* Aziyo Biologics Inc AZYO.OQ AZYO.O is expected to show
a
fall in quarterly revenue when it reports results on August
14.
* The Silver Spring Maryland-based company is expected to
report
a 1.1% decrease in revenue to $12.5 million from $12.64 million
a year ago, according to the estimate from one analyst, based on
Refinitiv data.
* Refinitiv's mean analyst estimate for Aziyo Biologics Inc
is
for a loss of 29 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Aziyo
Biologics
Inc is $8, above its last closing price of $1.38.
This summary was machine generated August 12 at 02:03 GMT. All
figures in US dollars unless otherwise stated